Clinical Trials Browser

Phase 2/3 × Mouth Neoplasms × Aspirin × Clear all

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Phase 2/3 Completed

Mouth Neoplasms